US 11834499
Claudin18 antibodies and methods of treating cancer
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11834499 (Claudin18 antibodies and methods of treating cancer) held by The Regents of the University of California expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 99
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K47/68031, A61K47/6849